Skip to main content

Table 2 Renal outcomes

From: Undetectable haptoglobin is associated with major adverse kidney events in critically ill burn patients

 

All patients (n = 130)

MAKE (n = 41)

No MAKE (n = 89)

p Value

Kidney aggression factors within 7 days, n (%)

 Aminoglycoside

5 (3.9)

5 (12.2)

0 (0)

0.0026

 Hydroxocobalamin

24 (18.5)

14 (34.1)

10 (11.2)

0.0031

 Shock (use of catecholamine)

58 (44.6)

34 (82.9)

24 (27)

<0.0001

AKI within 7 days, n (%)

73 (56.1)

39 (95.1)

34 (38.2)

<0.0001

KDIGO stage of patients with AKI within 7 days

2 (1–3)

3 (2–3)

1 (1–2)

<0.0001

Serum creatinine, μmol/L

Admission

67 (54–90)

88 (67–118)

64 (54–77)

<0.0001

 Maximum within 7 days

80 (65–113)

135 (85–206)

74 (64–86)

<0.0001

 ICU discharge (alive, without RRT)

49 (35–63)

64 (43–85)

49 (35–61)

0.07

Oliguria within 7 days, n (%)

63 (48.5)

35 (85.4)

28 (31.5)

<0.0001

RRT n (%)

 Within 7 days

18 (13.8)

18 (44)

0 (0)

<0.0001

 During ICU stay

26 (20)

26 (63.4)

0 (0)

<0.001

 Alive at ICU discharge

1 (0)

1 (2.4)

 
  1. Abbreviations: AKI Acute kidney injury, KDIGO Kidney Disease Improving Global Outcomes, ICU Intensive care unit, RRT Renal replacement therapy
  2. Data are expressed as median ± 25th–75th interquartile range for continuous variables and number (percent) for discrete variables